- Home
- CELC vs PAGS Comparison
CELC vs PAGS Comparison
Compare CELC & PAGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- PAGS
- Stock Information
- Founded
- CELC 2011
- PAGS 2006
- Country
- CELC United States
- PAGS Brazil
- Employees
- CELC N/A
- PAGS N/A
- Industry
- CELC Medical Specialities
- PAGS EDP Services
- Sector
- CELC Health Care
- PAGS Technology
- Exchange
- CELC Nasdaq
- PAGS Nasdaq
- Market Cap
- CELC 3.1B
- PAGS 2.9B
- IPO Year
- CELC 2017
- PAGS N/A
- Fundamental
- Price
- CELC $74.11
- PAGS $9.49
- Analyst Decision
- CELC Strong Buy
- PAGS Buy
- Analyst Count
- CELC 5
- PAGS 6
- Target Price
- CELC $69.40
- PAGS $11.83
- AVG Volume (30 Days)
- CELC 1.4M
- PAGS 3.9M
- Earning Date
- CELC 11-12-2025
- PAGS 11-12-2025
- Dividend Yield
- CELC N/A
- PAGS 1.48%
- EPS Growth
- CELC N/A
- PAGS 20.55
- EPS
- CELC N/A
- PAGS 1.30
- Revenue
- CELC N/A
- PAGS $3,543,799,551.00
- Revenue This Year
- CELC N/A
- PAGS $17.24
- Revenue Next Year
- CELC N/A
- PAGS $6.77
- P/E Ratio
- CELC N/A
- PAGS $7.43
- Revenue Growth
- CELC N/A
- PAGS 14.53
- 52 Week Low
- CELC $7.58
- PAGS $6.11
- 52 Week High
- CELC $83.00
- PAGS $11.16
- Technical
- Relative Strength Index (RSI)
- CELC 64.02
- PAGS 51.91
- Support Level
- CELC $71.06
- PAGS $9.22
- Resistance Level
- CELC $79.97
- PAGS $9.70
- Average True Range (ATR)
- CELC 5.13
- PAGS 0.29
- MACD
- CELC 0.11
- PAGS 0.03
- Stochastic Oscillator
- CELC 53.43
- PAGS 58.40
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About PAGS PagSeguro Digital Ltd.
PagSeguro Digital Ltd is a Brazilian-based company that acts as a provider of financial technology solutions focused on Micro-Merchants, Small Companies and Medium-Sized Companies (SMEs), in Brazil. The company provides a range of solutions and tools such as cash-in and cash-out options and provides access to working capital to help to manage its cash flow. It delivers an end-to-end digital ecosystem to address day-to-day financial needs, including receiving and spending funds and managing and growing businesses for clients. The company also offers the Free PagSeguro Digital Account delivering Cash-In Solutions, Online and In-Person Payment Tools, Online Payment Tools; and Web Check Outs offer tokenization, handling of shipping information, and others.